×
Site Menu
Everything
International Coverage
Legalization
Local Collectives
Investing
Mental Health
Recreation
Mushroom Culture
New Tech
Publications
Mushroom Science
Physical Benefits
Tryp Therapeutics merger with Exopharm approved by shareholders
Hypha Labs pivots to psilocybin with new mushroom tech
DEA resists permitting psilocybin for terminal patients under ‘Right to Try’
MDMA producer PharmAla issues 4.1M new shares to raise $750,000
Maine lawmakers pass bill to study psychedelic regulation
Clearmind signs agreement with Hebrew University for psychedelic compound rights
Numinus reports declining revenue as the company restructures
Filament’s pivots pay off, nets $2.1M revenue in 2023
MindMed taps out of Cboe
Algernon sells Ifenprodil, zooms in on DMT for stroke care
Latest
Tryp Therapeutics merger with Exopharm approved by shareholders
2 days ago
5
Hypha Labs pivots to psilocybin with new mushroom tech
2 days ago
7
DEA resists permitting psilocybin for terminal patients under ‘Right t...
2 days ago
8
MDMA producer PharmAla issues 4.1M new shares to raise $750,000
3 days ago
9
Maine lawmakers pass bill to study psychedelic regulation
1 week ago
15
Clearmind signs agreement with Hebrew University for psychedelic compo...
1 week ago
11
Numinus reports declining revenue as the company restructures
1 week ago
21
Filament’s pivots pay off, nets $2.1M revenue in 2023
3 weeks ago
27
MindMed taps out of Cboe
3 weeks ago
18
Algernon sells Ifenprodil, zooms in on DMT for stroke care
3 weeks ago
35
Compass Pathways co-founders exit to pursue ‘broader goals’
3 weeks ago
34
Atai cash purse down nearly half despite lower spending
4 weeks ago
35
Atai nasal spray hits mark in depression study
4 weeks ago
27
Alto Neuroscience is enjoying a solid cash cushion
1 month ago
30
Enveric Biosciences pins hopes on licensing deals
1 month ago
35
Psychedelic therapy program to launch in Utah
1 month ago
31
Relmada Therapeutics trims losses, slashes research costs
1 month ago
22
Seelos Therapeutics swings and misses on ALS drug study
1 month ago
21
Swedish study looks at psychedelic treatments for teens with psychotic...
1 month ago
26
Cybin to raise $150 million through private placement
1 month ago
42
BlueSky Wellness scraps merger with Lucy Scientific
1 month ago
41
JAMA article urges more surveillance over ketamine treatments
1 month ago
43
Mynd Life Sciences cuts losses, but faces going concern doubts
1 month ago
67
Atai kicks off DMT Phase 1 study
1 month ago
39
Compass widens Q4 loss as patient hurdles slow trials
1 month ago
77
Braxia Scientific cash dwindles even as revenues rise
1 month ago
66
GH Research pushes forward with DMT trials, drug approvals
1 month ago
62
Red Light Holland loses C$1.2 million in latest quarter
1 month ago
44
Psyence reports no revenue in Q4, but returns a profit
1 month ago
63
Psilocybin treatment beats placebo in Incannex anxiety study
1 month ago
52
Clearmind trials new alcohol disorder fix
1 month ago
69
Enveric sells cannabis patents to focus on psilocin candidates
2 months ago
67
Magic Mushroom Edibles: Everything to Know, from Chocolates to Drops
2 months ago
80
Psilocybin study for bipolar depression encourages more research
2 months ago
54
Prepping the psychedelic industry for MDMA approval
2 months ago
71
Pending Patents: Can Any Company Own Psilocybin?
2 months ago
50
Viridian Capital finds psychedelic stocks typically trade at 3x book
2 months ago
52
Filament Health exports psilocybin to Israel
2 months ago
59
Cybin reports strong cash reserves amid rising R&D costs in Q3
2 months ago
60
Bright Minds trims losses, but deficit grows
2 months ago
66
Doctor sues DEA to treat terminally ill patients with psilocybin
2 months ago
82
Police Officers Are Doing Ayahuasca Now
2 months ago
101
Study finds psychedelic users crowdsource to find ‘trip killers’
2 months ago
75
Study: Police seizures of psilocybin up 369% since 2017
2 months ago
79
Clearmind’s psychedelic portfolio expands with new Chinese patent
2 months ago
84
2024 kicks off with more states drafting psychedelic drug laws
2 months ago
104
Investors rally behind Numinus Wellness in a $6M bought deal
2 months ago
92
Oversubscribed and upsized Alto Neurosciences IPO begins trading today...
2 months ago
82
Numinus Wellness sells its stake in Alto Neurosciences
2 months ago
63
Huxley Health finalizes Sintalica deal, names Bruce Linton as new Chai...
2 months ago
105
Prev.
1
2
3
4
Next
Last
Trending
1.
Olu Fashanu
2.
Dallas Cowboys
3.
Patrick Mahomes
4.
Bell's palsy
5.
Lakers
6.
Kirk Cousins
7.
Rome Odunze
8.
Knicks
9.
Brock Bowers
10.
Bo Nix
Popular
Therapists Are Unprepared to Talk to People About Taking Psychedelics
What We Know (and Don’t) About Magic Mushroom Paralysis
How To Talk With Your Kids About Psychedelics
Uniform Model Law on Plants and Fungi Medicines: A Better Path to Reregulation
Psychedellux: The Psychedelic Industry News For The Week